NNH — New Nordic Healthbrands AB Cashflow Statement
0.000.00%
- SEK102.84m
- SEK122.14m
- SEK576.36m
Annual cashflow statement for New Nordic Healthbrands AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 28.5 | -4.75 | -3.17 | -4.45 | 15.1 |
| Depreciation | |||||
| Non-Cash Items | 0 | -0.287 | 0.349 | -0.021 | -0.042 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -37.4 | -12.1 | 28.9 | -3.56 | -9.19 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.87 | -15.5 | 28 | -5.4 | 8.39 |
| Capital Expenditures | -2.71 | -2.95 | -3.07 | -4.43 | -3.47 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.261 | 0.335 | -0.33 | 0.72 | 0.248 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.97 | -2.62 | -3.4 | -3.71 | -3.22 |
| Financing Cash Flow Items | — | — | 0.001 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12.1 | 16.6 | -21.2 | 10.4 | -3.38 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.48 | -1.18 | 3.11 | 1.43 | 1.3 |